Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(6 sites)
United States
Kivu Trial Site, Santa Monica, California Australia
Kivu Trial Site, Camperdown, New South Wales Kivu Trial Site, Sydney, New South Wales Kivu Trial Site, Brisbane, Queensland Kivu Trial Site, Adelaide, South Australia Kivu Trial Site, Geelong, Victoria